News – Page 127 – Endpoints News

Updated: GSK unintimidated by RSV vaccine uptake challenges, Shingrix US sales drop

10 months ago

Takeda takes $140M hit on Phase 3 epilepsy flop, previews late-stage trials for pipeline prospects

10 months ago

Umoja to dose first patient with in vivo CAR-T by end of this year

10 months ago

Biosecure lawmakers tell trade groups that China studies are a new focus

10 months ago

Exclusive: Myeloid Therapeutics moves second in vivo cell therapy into trials, targeting liver cancer

10 months ago

RNA editing startup AIRNA raises $60M for clinical trial in rare liver disease

10 months ago

FibroGen to shrink US workforce by 75% following more late-stage fails

10 months ago

Vertex gets January decision date for non-opioid pain medicine

10 months ago

Filing a new drug with clinical data in 2025? FDA sets fee at $4.3M

10 months ago

After a year of tumult, Pfizer manages to pull off a boring quarter

10 months ago

FDA shoots down second Novartis petition seeking to halt Entresto generics

10 months ago

China corruption crackdown hits Merck’s Gardasil sales, spooking investors

10 months ago

Behind Boehringer’s up to $1.3B Nerio deal is a budding cancer pipeline and aim to ‘leapfrog AbbVie’

10 months ago

Incyte drops four early-stage programs from its pipeline as part of strategic review

10 months ago

Imunon shares up over 150% as ovarian cancer treatment extends survival in Phase 2

10 months ago

Day One's $175M PIPE; Pinetree raises $17M in Series A

10 months ago

BioNTech, Regeneron claim Phase 2 win for cancer vaccine, PD-1 combo

10 months ago

Pfizer ups 2024 guidance by $1B after multiple rounds of cost cuts

10 months ago

Celldex says antibody drug improves irritable skin condition in Phase 2 test

10 months ago

Exclusive: Startup aims to tackle ‘undruggable’ neuro targets with tech from Kevan Shokat's UCSF lab

10 months ago

Keytruda tops $7B quarterly sales for the first time

10 months ago

Roche begins Phase 2 obesity trial for GLP-1/GIP agonist, striking while iron is hot

10 months ago

Bessemer VC Morgan Cheatham shares how AI healthcare startups can win in a crowded market

10 months ago

AstraZeneca and Daiichi Sankyo fail to win NICE recommendation for Enhertu, call for change to review process

10 months ago

First page Previous page 124 125 126127128 129 130 Next page Last page